The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document
Open accessAbstract
Myocarditis is an inflammatory disease of the heart that may occur because of infections, immune system activation, or exposure to drugs. The diagnosis of myocarditis has changed due to the introduction of cardiac magnetic resonance imaging. We present an expert consensus document aimed to summarize the common terminology related to myocarditis meanwhile highlighting some areas of controversies and uncertainties and the unmet clinical needs. In fact, controversies persist regarding mechanisms that determine the transition from the initial trigger to myocardial inflammation and from acute myocardial damage to chronic ventricular dysfunction. It is still uncertain which viruses (besides enteroviruses) cause direct tissue damage, act as triggers for immune-mediated damage, or both. Regarding terminology, myocarditis can be characterized according to etiology, phase, and severity of the disease, predominant symptoms, and pathological findings. Clinically, acute myocarditis (AM) implies a short time elapsed from the onset of symptoms and diagnosis (generally <1 month). In contrast, chronic inflammatory cardiomyopathy indicates myocardial inflammation with established dilated cardiomyopathy or hypokinetic nondilated phenotype, which in the advanced stages evolves into fibrosis without detectable inflammation. Suggested diagnostic and treatment recommendations for AM and chronic inflammatory cardiomyopathy are mainly based on expert opinion given the lack of well-designed contemporary clinical studies in the field. We will provide a shared and practical approach to patient diagnosis and management, underlying differences between the European and US scientific statements on this topic. We explain the role of histology that defines subtypes of myocarditis and its prognostic and therapeutic implications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“cardiotropic viruses such as adenoviruses and enteroviruses can directly damage the heart, leading to the development of myocarditis”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“certain viruses including HIV, hepatitis C virus, influenza A virus, and influenza B virus are thought to trigger myocarditis by activating the immune system”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“with up to 20% of giant cell myocarditis cases associated with existing autoimmune disorders such as inflammatory bowel disease, thyroiditis, and thymoma.”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Giant cell myocarditis and eosinophilic necrotizing myocarditis are traditionally classified as autoimmune myocarditis due to their strong association with existing autoimmune conditions”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In well-known forms of autoimmune myocarditis such as giant cell myocarditis and cardiac sarcoidosis, macrophages have been identified as a significant contributor to the formation of multinucleated giant cells or granulomas”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [31]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“suggesting potential alternative pathogenesis such as autoimmunity, hypersensitivity, or medication usage.”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lymphocytic myocarditis is primarily associated with viral infections, characterized by histological observations of myocardial infiltration predominantly by T lymphocytes”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, in some cases of lymphocytic myocarditis, these viruses tested negative, while autoantibodies specific to the heart were present”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which can be pleuritic and positional, similar to that of pericarditis, or pressure-like mimicking the pain of acute coronary syndrome.”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the most commonly reported symptom is chest pain (82% to 95% of cases)”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sarcoidosis is a systemic autoimmune syndrome characterized by the formation of nonnecrotizing granulomas, a histological hallmark, found in various organs including the lung and heart.”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“an unnoticed history of viral infection may contribute to the migration and activation of autoreactive T cells in the heart. 7,10,31,107”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Giant cell myocarditis is a rare but rapidly progressing condition associated with a high risk of death or the necessity for heart transplantation.”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“Histopathologic observations reveal myocardial infiltration of multinucleated giant cells along with lymphocytes and eosinophils in this condition.”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“various conditions including infections, drugs, hypersensitivity, and autoimmune factors may be associated with the onset and progress of this disease.”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479
Self-citationCardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
Friedrich, M. G., Sechtem, U. P., Schulz‐Menger, J., Holmvang, G., Alakija, P., Cooper, L. T., White, J. A., Abdel‐Aty, H., Gutberlet, M., Prasad, S. K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.007 · Cited by 2,523
Self-citationFulminant Myocarditis with Combination Immune Checkpoint Blockade
Johnson, D. B., Balko, J. M., Compton, M. L., Chalkias, S., Gorham, J., Xu, Y., Hicks, M., Puzanov, I., Alexander, M. R., Bloomer, T. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609214 · Cited by 2,308
Self-citationCardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation
Ferreira, V. M., Schulz-Menger, J., Holmvang, G., Kramer, C. M., Carbone, I., Sechtem, U., Kindermann, I., Gutberlet, M., Cooper, L. T., Liu, P., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.072 · Cited by 2,059
Self-citationAl‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,902
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
Inciardi, R. M., Lupi, L., Zaccone, G., Italia, L., Raffo, M., Tomasoni, D., Cani, D., Cerini, M., Farina, D., Gavazzi, E., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1096 · Cited by 1,896
Self-citationMyocarditis in Patients Treated With Immune Checkpoint Inhibitors
Mahmood, S. S., Fradley, M. G., Cohen, J. V., Nohria, A., Reynolds, K. L., Heinzerling, L. M., Sullivan, R. J., Damrongwatanasuk, R., Chen, C. L., Gupta, D., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.037 · Cited by 1,608
Self-citationHaslam, A., & Prasad, V. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.2535 · Cited by 1,413
Research works printed but not linked: 1
- 10.1161/CIR0000000000000745 · DOI
Cited by
Sorted by citations
Items 301–400 of 849
Molecular imaging of cardiovascular disease: Current status and future perspective
Nakahara, T., Fujimoto, S., & Jinzaki, M. (2025) · Journal of Cardiology · doi:10.1016/j.jjcc.2025.01.017 · Cited by 7
Chitroda, N., Mithaiwala, A., & Godad, A. P. (2025) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2025.2528001 · Cited by 7
Inflammatory cardiomyopathy: an update for clinicians
Imazio, M. (2025) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2025.07.003 · Cited by 7
Ricci, J. F., Farahani, N. A. S., Davis, C., Ritter, K. G., Parrow, L. M., Tomerlin, P. I., Darakjian, A. A., Gegoutchadze, K., Gupta, D., & Bruno, K. A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1601307 · Cited by 8
Zhuang, Y., Yan, Y., Zheng, W., Rao, X., Jiang, J., Li, H., & Wang, D. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103970 · Cited by 7
Imazio, M., Collini, V., Merlo, M., Aimo, A., Autore, C., Barison, A., Bauce, B., Biagini, E., Cappelli, F., Castelletti, S., et al. (2026) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2026.01.002 · Cited by 7
Batalov, R. E., Хлынин, М. С., Rogovskaya, Y., Sazonova, S. I., Tatarskiy, R. B., Anfinogenova, Y., & Popov, S. V. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041254 · Cited by 7
Paradigm shift in myocarditis treatment
Yakhshimurodov, U. R., Yamashita, K., Kawamura, T., Kawamura, M., & Miyagawa, S. (2023) · Journal of Cardiology · doi:10.1016/j.jjcc.2023.08.009 · Cited by 7
Prostaglandin E2 and myocarditis; friend or foe?
Bryson, T. D., & Harding, P. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115813 · Cited by 7
Myocarditis: A multi-omics approach
Wang, L., Sun, T., Liu, X., Wang, Y., Qiao, X., Chen, N., Liu, F., Zhou, X., Wang, H. X., & Shen, H. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117752 · Cited by 7
A Narrative Review of Preclinical In Vitro Studies Investigating microRNAs in Myocarditis
Grodzka, O., Procyk, G., & Wrzosek, M. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46020091 · Cited by 7
Bohbot, Y., Pezel, T., Demirkıran, A., Androulakis, E. S., Houshmand, G., Szabó, L. E., Manka, R., Lembo, M., Botezatu, S., Rodríguez-Palomares, J. F., et al. (2024) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeae092 · Cited by 7
Suzuki, S., Ito, K., Teraoka, N., Okuma, Y., Kimura, K., Minamisawa, M., Ebisawa, S., Motoki, H., Imamura, H., Seto, T., et al. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14931 · Cited by 7
Management Status of Myocarditis-Related Sudden Cardiac Death
Yan, P., Yang, S., & Wang, T. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2512452 · Cited by 9
Infarct-like myocarditis in adolescents: Exploring genetic insights from diagnosis through follow-up
Esmel-Vilomara, R., Riaza, L., Dolader, P., Rodríguez‐Santiago, B., Lasa‐Aranzasti, A., Muñoz‐Cabello, P., Fernández‐Álvarez, P., Figueras-Coll, M., Bianco, L., Bueno-Gómez, A., et al. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133255 · Cited by 7
Horiuchi, K., Kosugi, S., Abe, H., & Ueda, Y. (2022) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytac290 · Cited by 7
Multimodality imaging in acute myocarditis
Muscogiuri, G., Guaricci, A. I., Cau, R., Saba, L., Senatieri, A., Chierchia, G., Pontone, G., Volpato, V., Palmisano, A., Esposito, A., et al. (2022) · Journal of Clinical Ultrasound · doi:10.1002/jcu.23310 · Cited by 7
Ammirati, E., Vandenbriele, C., & Nascimbene, A. (2023) · Circulation Heart Failure · doi:10.1161/circheartfailure.123.010670 · Cited by 7
Self-citationCardiac Macrophages across Space and Time: Roles in Homeostasis, Disease, and Remodeling
Shrestha, S., & Dick, S. A. (2026) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2026.02.025 · Cited by 7
Evolution in the Diagnosis and Treatment of Myocarditis in Recent Years: State of the Art
Campodonico, J., Lauri, C., Pezzuto, B., Agostoni, P., & Vignati, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14217661 · Cited by 6
Catheter Ablation for Ventricular Tachycardia in Patients With Biopsy-Proven Myocarditis
Li, L., Ding, L., Liu, S., Wu, L., Zheng, L., Xiong, Y., Zhang, Z., Zhou, L., & Yao, Y. (2024) · JACC Asia · doi:10.1016/j.jacasi.2024.08.018 · Cited by 6
Therapeutic management of inflammatory heart diseases
Bonaventura, A., Buono, M. G. D., Golino, M., Potere, N., Vecchié, A., Malandrino, D., Tassell, B. W. V., Youngstein, T., Weber, B. N., & Abbate, A. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.108996 · Cited by 6
Thai, T. B. T., Kang, Y.-N., Nguyen, H. S., Tran, K. V., Vo, H. H., Phúc, P. H., Chen, S.-Y., Loh, E., & Tam, K. (2026) · Pediatric Research · doi:10.1038/s41390-025-04655-0 · Cited by 6
Neurological Manifestations of Myocarditis
Trifan, G., & Testai, F. D. (2022) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-022-01203-9 · Cited by 6
Sur, M., Rasquinha, M. T., Arumugam, R., Massilamany, C., Gangaplara, A., Mone, K., Lasrado, N., Yalaka, B., Doiphode, A., Gurumurthy, C. B., et al. (2023) · Cells · doi:10.3390/cells12192346 · Cited by 8
Kandels, J., Richter, S., Hagendorff, A., Kragholm, K. H., Tayal, B., Laufs, U., Denecke, T., & Stöbe, S. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1322145 · Cited by 6
Fulminant Myocarditis Temporally Associated with COVID-19 Vaccination
Ammirati, E., Conti, N., Palazzini, M., Rocchetti, M., Spangaro, A., Garascia, A., Lupi, L., & Cereda, A. F. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02021-w · Cited by 6
Self-citationRed Flags in Acute Myocarditis
Hashmani, S., Manla, Y., Matrooshi, N. A., & Bader, F. M. (2024) · Cardiac failure review · doi:10.15420/cfr.2023.02 · Cited by 6
Tabatabaei, F., Shafeghat, M., Azimi, A., Akrami, A. E., & Rezaei, N. (2024) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2024.2392815 · Cited by 6
Suzuki, S., Teraoka, N., Ito, K., Okuma, Y., Kimura, K., Minamisawa, M., Ebisawa, S., Motoki, H., IMAMURA, H., Seto, T., et al. (2024) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2024.07.023 · Cited by 6
Outcomes of definite vs probable/presumed cardiac sarcoidosis: a systematic review and meta-analysis
Ahmed, R., Ahsan, A., Ahmed, M., Dragon, M., Caballero, R. R. H., Tabassum, S., Jain, H., Ullah, M. Z. S., Dey, D., Ramphul, K., et al. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102820 · Cited by 6
Lisi, D. D., Madaudo, C., Carmina, M. G., Clemenza, F., Scelfo, D., Franca, E. L., Pieri, M., Vitale, G., Galassi, A. R., & Novo, G. (2024) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2024.100458 · Cited by 6
The Role of MicroRNA in the Pathophysiology and Diagnosis of Viral Myocarditis
Młynarska, E., Badura, K., Kurciński, S., Sinkowska, J., Jakubowska, P., Rysz, J., & Franczyk, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010933 · Cited by 6
Drug-induced noninfectious myocarditis: a disproportionality analysis of the FAERS database
Yan, L., & Zheng, G. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2423679 · Cited by 6
Omori, T., Maruyama, K., Ohta‐Ogo, K., Hatakeyama, K., Ishibashi‐Ueda, H., Onoue, K., Nagai, T., Kato, S., Okumura, T., Oikawa, M., et al. (2024) · Circulation Journal · doi:10.1253/circj.cj-24-0506 · Cited by 6
Association between human blood metabolome and risk of myocarditis: a mendelian randomization study
Wang, Z., Tian, H., & Wang, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-78359-6 · Cited by 6
Diagnostic and prognostic values of HCG15 and morrbid in acute myocardial infarction
Huang, M., Wu, B., Xu, O., Sun, S., Han, K., Li, L., Liang, H., Qiu, C., & Xu, Q. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1492746 · Cited by 6
Lauriero, F., Vita, C. H., Perazzolo, A., Sanseverino, G., Moliterno, E., Rovere, G., Marano, R., & Natale, L. (2025) · Echocardiography · doi:10.1111/echo.70099 · Cited by 6
Veeram, A., Patekar, R. R., Bharate, S. B., Andugulapati, S. B., & Sistla, R. (2025) · Phytotherapy Research · doi:10.1002/ptr.8453 · Cited by 6
Ogunniyi, K. E., Djunadi, T. A., Adewara, O., Babawale, I., Akinmoju, O. D., Olaiya, V. O., Nwatamole, B. C., Shazad, S., Patel, D., Popoola, H. A., et al. (2025) · Cardiovascular Toxicology · doi:10.1007/s12012-025-10038-y · Cited by 6
Takura, T., Ōno, M., Ako, J., Ikari, Y., Toda, K., Sawa, Y., & for the ETICA Study Investigators (2022) · Circulation Journal · doi:10.1253/circj.cj-22-0439 · Cited by 6
Delayed presentation of biopsy-proven eosinophilic myocarditis following COVID-19 mRNA vaccine
Janga, C., Patel, T. R., Hennawi, H. A., Atam, S., Shah, S., NAEEM, I., Memon, R. A., & Haas, D. C. (2023) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2023.10 · Cited by 6
Sex-based differences in late gadolinium enhancement among patients with acute myocarditis
Cau, R., Pisu, F., Suri, J. S., Montisci, R., Bastarrika, G., Esposito, A., & Saba, L. (2023) · European Journal of Radiology · doi:10.1016/j.ejrad.2023.110980 · Cited by 6
Sintilimab-Induced Myocarditis in a Patient with Gastric Cancer: A Case Report and Literature Review
Liu, X., Zeng, Z., Cao, J., Li, X., Muhetaer, M., Jin, Z., Cai, H., & Lu, Z. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10100422 · Cited by 6
Park, J., & Kim, K. H. (2024) · Korean Circulation Journal · doi:10.4070/kcj.2024.0065 · Cited by 6
Clinical significance of chronic myocarditis: systematic review and meta-analysis
Hirono, K., Takarada, S., Okabe, M., Miyao, N., Nakaoka, H., Ibuki, K., Ozawa, S. W., Origasa, H., Ichida, F., & Imanaka‐Yoshida, K. (2021) · Heart and Vessels · doi:10.1007/s00380-021-01914-y · Cited by 6
Enterovirus fulminant myocarditis as cause of acute heart failure in a newborn
Annoni, G. A., Rienzo, F. D., Nonini, S., Pugni, L., Marianeschi, S., Mauri, L., Gatelli, I. F., Mauri, L., Aresta, F., Bramerio, M., et al. (2022) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2022.101093 · Cited by 6
Self-citationAn Update on the Role of Cardiac Magnetic Resonance Imaging in Cancer Patients
Riverola, A. P., & Ghosh, A. K. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01818-x · Cited by 6
Case report: Electrocardiographic changes in pembrolizumab-induced fatal myocarditis
Nishiyama, K., Morikawa, K., Shinozaki, Y., Ueno, J., Tanaka, S., Tsuruoka, H., Azagami, S., Ishida, A., Yanagisawa, N., Akashi, Y. J., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1078838 · Cited by 6
Editorial: Acquired Heart Disease in Children: Pathogenesis, Diagnosis and Management
Liao, Y., Jin, H., Huang, X., Gong, F., & Fu, L. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.725670 · Cited by 6
Incidence, diagnosis, and prognosis of myocarditis: does gender matter?
Piccirillo, F., Nusca, A., & Sciascio, G. D. (2022) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16246 · Cited by 6
Wang, S., Xu, H., Guo, Z., Tian, Y., Guo, X., Chu, H., & Wang, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1597427 · Cited by 5
Barison, A., Aquaro, G. D., Dellegrottaglie, S., Rizzo, S., Luca, A. D., Maestrini, V., Scatteia, A., Baggiano, A., Gaspari, M. D., Filardi, P. P., et al. (2025) · Circulation · doi:10.1161/circulationaha.124.072926 · Cited by 5
Self-citationCardiomyocyte β-arrestins mediate inflammation and cGAS-STING activation in CVB3 viral myocarditis
Lucero, E. Y., Jiang, H., D’Anniballe, V. M., Pakharukova, N., Galtes, D., Bassford, D. K., Jyothidasan, A., Knowlton, K. U., Gunn, M. D., Lefkowitz, R. J., et al. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00589.2025 · Cited by 5
Ammirati, E., Cartella, I., Ciabatti, M., Colombo, G., Masetti, M., Pieroni, M., Gallone, G., Peretto, G., Potena, L., Scacciavillani, R., et al. (2026) · ESC Heart Failure · doi:10.1093/eschf/xvag058 · Cited by 5
Self-citationImazio, M., Jahnsen, V., Merlo, M., Aimo, A., Autore, C., Barison, A., Bauce, B., Biagini, E., Bobbio, E., Cappelli, F., et al. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2026.134249 · Cited by 7
Mitrokhin, V. M., Kamkin, A. G., Babkina, I., Savinkova, I. G., Shileiko, S. A., Сергеевич, О. Р., & Mladenov, M. I. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062603 · Cited by 5
Diagnostic and Therapeutic Options in Myocarditis and Inflammatory Cardiomyopathy
Schultheiss, H., Escher, F., Aleshcheva, G., Wiegleb, G., & Baumeier, C. (2026) · Biomedicines · doi:10.3390/biomedicines14030691 · Cited by 5
Self-citationThe cardiovascular-immune axis: crosstalk and therapy in atherosclerosis, myocarditis and vasculitis
Liao, Y.-P., Wei, Y., Zhang, F.-M., Zhang, Z.-S., Xu, S.-P., You, Y., & Guo, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1781248 · Cited by 5
Taşkesen, T., Osei, K. M., Hamilton, R., Marcus, R. H., Martin, E., & Manola, A. (2021) · Journal of Cardiovascular Echography · doi:10.4103/jcecho.jcecho_125_20 · Cited by 5
Dandel, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206451 · Cited by 5
Pieroni, M., Ciabatti, M., Zocchi, C., Tavanti, V., Camporeale, A., Saletti, E., Fumagalli, C., Venezia, D., Lombardi, M., Olivotto, I., et al. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131603 · Cited by 5
Shalata, W., Steckbeck, R., Salman, A. A., Saleh, O. A., Jama, A. A., Attal, Z. G., Shalata, S., Alnsasra, H., & Yakobson, A. (2024) · Medicina · doi:10.3390/medicina60020224 · Cited by 5
Ibrahim, E. H., Rubenstein, J., Sosa, A., Stojanovska, J., Pan, A., North, P. E., Rui, H., & Benjamin, I. J. (2024) · Tomography · doi:10.3390/tomography10030026 · Cited by 5
Return-to-Play Post-Myocarditis for Athletes: To Play or Not to Play?
Yamagata, K., & Malhotra, A. (2024) · Diagnostics · doi:10.3390/diagnostics14192236 · Cited by 8
Ruscitti, P., Cola, I. D., Vitale, A., Caggiano, V., Palumbo, P., Cesare, E. D., Torres-Ruiz, J. J., Guaracha-Basáñez, G. A., Martín‐Nares, E., Ciccia, F., et al. (2024) · The Journal of Rheumatology · doi:10.3899/jrheum.2024-0683 · Cited by 5
Veronese, G., Nonini, S., Cannata, A., Aresta, F., Olivieri, G. M., Montrasio, E., Caria, D. D., Perna, E., Calini, A., Bottiroli, M., et al. (2022) · Circulation Heart Failure · doi:10.1161/circheartfailure.122.009810 · Cited by 5
Self-citationFujii, M., Toba, T., Fukuyama, Y., Tjan, L. H., Mori, Y., & Hirata, K. (2023) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytad063 · Cited by 5
Chen, X., Zhang, Q., Song, T., Zhang, W., Yang, Y., Duan, N., & Cong, F. (2023) · Gene · doi:10.1016/j.gene.2023.147388 · Cited by 5
Collini, V., Burelli, M., Favaretto, V., Pegolo, E., Fumarola, F., Lepre, V., Pellin, L., Taurian, M., Quartuccio, L., Imazio, M., et al. (2023) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.23.06287-7 · Cited by 5
Holmström, L. T. A., Chaudhary, N. S., Nakamura, K., Chugh, H. S., Uy‐Evanado, A., Norby, F. L., Metcalf, G., Menon, V. K., Yu, B., Boerwinkle, E., et al. (2023) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.123.004105 · Cited by 5
Mesalazine-induced myopericarditis: a case series
Andrei, V., D’Ettore, N., Scheggi, V., & Mario, C. D. (2023) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytad424 · Cited by 5
Perimyocarditis in a Patient with Ulcerative Colitis Treated with 5-Aminosalicylic Acid
Lee, H. Y., & Baek, D. H. (2024) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2024.024 · Cited by 5
Cau, R., Pisu, F., Muscogiuri, G., Suri, J. S., Montisci, R., & Saba, L. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11070191 · Cited by 5
Jain, L., Kaur, D., Khalil, S., Pradhan, P., Malik, M., Dogra, S., Kaur, K., & Mathew, J. L. (2025) · Indian Pediatrics · doi:10.1007/s13312-025-3359-5 · Cited by 5
Endomyocardial Biopsy: Short- and Long-Term Safety in Myocarditis Patients
Li, Z.-P., Li, G., Wang, Y.-N., Yang, H., Wang, L., Cui, G.-L., Miao, K., & Jiang, J. (2025) · Cardiology · doi:10.1159/000543593 · Cited by 5
Multifunctional nanoparticles for immune regulation and oxidative stress alleviation in myocarditis
Ye, Z., Zhu, M., Li, S., Zhang, F., Ran, Y., Liu, C., Xu, X., Liu, S., Xie, X., Wang, Y., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113607 · Cited by 5
Pelliccia, F., Marzilli, M., Boden, W. E., & Camici, P. G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204630 · Cited by 5
Self-citationRinkūnaitė, I., Šimoliūnas, E., Alksnė, M., Bartkutė, G., Labeit, S., Bukelskienė, V., & Bogomolovas, J. (2022) · Biomolecules · doi:10.3390/biom12121898 · Cited by 6
Myocarditis Following COVID-19 Vaccination: A Systematic Review
Shaheen, N., Ramadan, A., Shaheen, A., Elmasry, M., Swed, S., Hafez, W., & Wael, M. (2023) · Cureus · doi:10.7759/cureus.37999 · Cited by 7
Zonulina e Presepsina Poderiam ser Biomarcadores e Alvos Terapêuticos para Miocardite Aguda?
Toprak, K., İnanır, M., Memioğlu, T., Kaplangöray, M., Palice, A., & Taşcanov, M. B. (2023) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20230017 · Cited by 5
Hofrichter, P., Hagendorff, A., Laufs, U., Fikenzer, S., Hepp, P., Marshall, R. P., Tayal, B., & Stöbe, S. (2021) · International journal of cardiac imaging · doi:10.1007/s10554-021-02213-3 · Cited by 5
Daoud, A., Kalinoski, H., Talor, M. V., Welsh, R. A., Jo, W., Jaime, C. M., Kolim, B., Mahto, N., Kveton, M., Weislová, I., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf209 · Cited by 4
Basuoni, A., Makhlouf, M., Dawelbeit, W., Ahmed, D., Al-Sharqi, H., Farsi, S. A., & Al-Baimani, K. S. (2025) · Medical Reports · doi:10.1016/j.hmedic.2025.100345 · Cited by 4
Sridhar, K. C., Mehl, J., Klingel, K., Thiele, M., Linthout, S. V., Tschöpe, C., Duda, G. N., & Viola Vogel, B. (2025) · Matrix Biology Plus · doi:10.1016/j.mbplus.2025.100182 · Cited by 4
Self-citationSTING-Targeted PET Imaging for Specific Detection and Therapeutic Monitoring of Myocarditis
Ye, Z., Lu, X., Zhu, M., Bi, L., Yang, F., Zhou, B., Xu, D., & Yao, L. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00024 · Cited by 4
Zemkova, M., Rob, D., Dusík, M., Pudil, J., Paleček, T., Vítková, I., & Bělohlávek, J. (2024) · ESC Heart Failure · doi:10.1002/ehf2.15001 · Cited by 4
Dominici, L., Marchitelli, L., Ruoli, L., Conia, L., Cundari, G., Pambianchi, G., Catalano, C., & Galea, N. (2024) · Journal of Medical Imaging and Interventional Radiology · doi:10.1007/s44326-024-00026-x · Cited by 4
Kurnik, M., Kolar, P., Krepek, M., Vlaović, J., & Podbregar, M. (2024) · Immunotherapy · doi:10.1080/1750743x.2024.2427563 · Cited by 4
Campylobacter jejuni-Related Myocarditis: A Case Report and Review of the Literature
Zouganeli, V., Kourek, C., Bistola, V., Mademli, M., Grigoropoulos, I., Thomas, Κ., Tsiodras, S., Filippatos, G. S., & Farmakis, D. T. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13247551 · Cited by 4
Liu, W., Mao, Y., Li, H., Hu, J., Gan, T., Wang, Y., Wang, Z., & Wang, Z. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177292 · Cited by 5
Cau, R., Falconi, G., Suri, J. S., & Saba, L. (2025) · Clinical Radiology · doi:10.1016/j.crad.2025.107007 · Cited by 4
Kronzer, E. K., Hagan, G., Ledet, C., Knott, J. D., Bois, J. P., Askew, J. W., & Chareonthaitawee, P. (2025) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2025.08.004 · Cited by 4
Puetz, A., Berger, M., Lebherz, C., Bauermann, K., Hartmann, N. K., Kappel, B. A., Dettori, R., Nonnast, A., Dirrichs, T., Maruhn, K., et al. (2025) · Open Heart · doi:10.1136/openhrt-2025-003508 · Cited by 4
Nakanishi, N., Hara, S., Nagaharu, K., Matsuyama, R., Fujita, S., Nakamori, S., Okamoto, R., Dohi, K., Hiroe, M., Imanaka‐Yoshida, K., et al. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag057 · Cited by 4
Kang, N., Friedrich, M. G., Abramov, D., Martinez–Naharro, A., Fontana, M., & Parwani, P. J. (2023) · Heart Failure Clinics · doi:10.1016/j.hfc.2023.03.009 · Cited by 5
Self-citationMyocarditis in Athletes: Risk Factors and Relationship with Strenuous Exercise
Terry, K. J., Narducci, D. M., Moran, B., Chang, P., Orlando, D., Bindas, B., Botto, E., Retzloff, A., Esan, D., & Coris, E. E. (2023) · Sports Medicine · doi:10.1007/s40279-023-01969-z · Cited by 5
Multisystemic Inflammation Influences Prognosis in Fulminant Lymphocytic Myocarditis
Kawano, H., Ikeda, S., Kanaoka, K., Sato, S., Eto, R., Ueno, Y., Onoue, K., Saito, Y., Maemura, K., & the Japanese Registry of Fulminant Myocarditis Investigators (2024) · Circulation Journal · doi:10.1253/circj.cj-23-0914 · Cited by 4
Yang, Q., Qin, J., Li, Z., He, Y., & Zhou, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1453946 · Cited by 4
Ring-like late gadolinium enhancement: differential diagnosis and mimics
Vaz, A., Morales, K. R. D. P., Fonseca, E. K. U. N., de Souza, J. P., Rahal, M. J. S., Young, L. M., Pereira, L. M., Scoppetta, L. R. P. D., & Filho, J. R. P. (2025) · Radiologia Brasileira · doi:10.1590/0100-3984.2024.0111 · Cited by 4
Metadata
- Authors
- Ammirati, E., Frigerio, M., Adler, E. D., Basso, C., Birnie, D. H., Brambatti, M., Friedrich, M. G., Klingel, K., Lehtonen, J., Moslehi, J. J., Pedrotti, P., Rimoldi, O. E., Schultheiss, H.-P., Tschöpe, C., Cooper, L. T., & Camici, P. G.
- Affiliations
- Vita-Salute San Raffaele University (IT)
- Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT)
- University of California San Diego (US)
- University of Padua (IT)
- Ottawa Heart Institute (CA)
- Ionis Pharmaceuticals (United States) (US)
- McGill University (CA)
- Universitätsklinikum Tübingen (DE)
- Helsinki University Hospital (FI)
- Vanderbilt University Medical Center (US)
- IBFM CNR, Segrate, Italy (O.E.R.).
- Institute for Cardiac Diagnostics and Therapy, Berlin, Germany (H.-P.S.).
- Berlin-Brandenburger Centrum für Regenerative Therapien (DE)
- Mayo Clinic (US)
- Corresponding author
- Ammirati, Enrico
- Camici, Paolo G.
- ORCID
- Venue
- Circulation: Heart Failure
- Published
- 2020-11
- Volume
- 13
- Issue
- 11
- Pages
- e007405-e007405
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- PMC
- PMC7673642
- OpenAlex
- W3103940138
- Semantic Scholar
- beb20d26bcaef45ecb6c5c865df17930929b84c5
- Cited by
- 811
- References
- 123
- Citations by year
- 2026: 122 · 2025: 155 · 2024: 185 · 2023: 150 · 2022: 137 · 2021: 60 · 2020: 1
- FWCI
- 53.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation Heart Failure (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Deutsches Zentrum für Herz-Kreislaufforschung
- Bundesministerium für Bildung und Forschung
- Regione del Veneto
- National Heart, Lung, and Blood Institute (R01HL141466, R01HL155990)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Pericarditis and Cardiac Tamponade
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- acute myocarditis, dilated cardiomyopathy, myocarditis, cardiac magnetic resonance imaging, viral myocarditis, myocardial fibrosis, histopathology, prognosis, treatment guidelines, expert consensus
- MeSH terms
- Acute Disease, Cardiology, Chronic Disease, Humans, Myocarditis, Terminology as Topic, Predictive Value of Tests, Risk Factors, Treatment Outcome, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
